Almirall

Almirall

Fabricación de productos farmacéuticos

Feel the Science

Sobre nosotros

Almirall is a global biopharmaceutical company focused on medical dermatology. Founded in 1944 and with headquarters in Barcelona (Spain), our purpose is at the core of our work: “Transform the patients’ world by helping them realize their hopes and dreams for a healthy life”. Through pharmaceutical innovation, investment in R&D and strong commitment to global healthcare partnerships, we develop and commercialize solutions with specific focus on dermatological diseases such as psoriasis, actinic keratosis, atopic dermatitis or acne. We care and listen to our patients’ needs. We find solutions for them. We aim to empower them. Almirall has 1 R&D center, 2 chemical plants and 2 pharmaceutical plants. Our more than 1,900 employees make it possible for our treatments to be available in over 100 countries across 5 continents, through our 15 global affiliates and via a strategic partnership network. Almirall is listed on the Spanish Stock Exchange (ticker: ALM).

Sitio web
http://www.almirall.com
Sector
Fabricación de productos farmacéuticos
Tamaño de la empresa
De 1.001 a 5.000 empleados
Sede
Barcelona
Tipo
Empresa pública
Fundación
1944
Especialidades
Dermatology (Actinic keratosis, Atopic Dermatitis, Eczema, Inflammatory Skin Conditions, Psoriasis, Rosacea, Severe Acne), OTC Products, Other Specialty Areas (e.g. Spasticity in Multiple Sclerosis) y Medical Device

Ubicaciones

  • Principal

    Ronda General Mitre, 151

    Barcelona, 08022, ES

    Cómo llegar
  • Carretera Laureà Miró, 408

    Sant Feliu de Llobregat, Barcelona 08980, ES

    Cómo llegar
  • Carretera de Martorell 41-61

    Sant Andreu de la Barca, Barcelona 08740 , ES

    Cómo llegar

Empleados en Almirall

Actualizaciones

  • Ver la página de empresa de Almirall, gráfico

    129.903 seguidores

    🎉This year at Almirall, we celebrate our 80th anniversary.   Over the past 8 decades, we’ve grown from developing medicines at a small site in Barcelona to a global leader in the pharmaceutical industry, with 2,000 employees across Europe and the US. As a family-owned company, our legacy is grounded in a long-term vision of creating innovative solutions that support people living with diseases and the medical community.   Let’s celebrate our 80 years of achievements as a foundation for our future.   Discover our history at https://lnkd.in/dZZXY5XR   #Almirall80Years #WeAreAlmirall

  • Ver la página de empresa de Almirall, gráfico

    129.903 seguidores

    Our mission is driven by a profound commitment to care for those living with skin diseases while empowering our employees and uplifting our community, envisioning a healthier future for all. On this #WorldMentalHealthDay, we highlight the urgent need to prioritize mental health. By engaging in this vital conversation, we can foster an environment that supports everyone's mental wellbeing and resilience. Let’s work together to create a world where mental health is valued, empowering everyone to thrive. #WorldMentalHealthDay #Wellbeing

    • No hay descripción de texto alternativo para esta imagen
  • Ver la página de empresa de Almirall, gráfico

    129.903 seguidores

    📢 After another successful edition, we are proud to have participated in the European Academy of Dermatology and Venereology Annual Congress (EADV) in Amsterdam. The #EADV Congress continues to be a pivotal platform for advancing scientific research, discovering new collaboration opportunities, and exploring the latest developments in our field. We extend our gratitude to the organizers and all the experts in the field of dermatology who made this event a success, and we look forward to next edition! #EADVCongress #MedicalDermatology #WeAreAlmirall

  • Ver la página de empresa de Almirall, gráfico

    129.903 seguidores

    This week, we will be present at CPHI Milan 2024, a leading event for the pharmaceutical industry. From October 8 to 10, we will join over 62,000 attendees and 2,400 companies from 166 countries to explore the future of the pharmaceutical sector and drive innovation. For 35 years, CPHI has served as a key platform for collaboration and knowledge exchange, bringing together industry leaders to advance human health. This year, we remain committed to working closely with experts from around the world to keep developing cutting-edge technologies. We look forward to connecting with all of you in Milan to shape the future of healthcare together! #Innovation #CPHI #AtTheHeartOfPharma #WeAreAlmirall

    • No hay descripción de texto alternativo para esta imagen
  • Ver la página de empresa de Almirall, gráfico

    129.903 seguidores

    Transform psoriasis care: Join the #PsOlve challenge!   We are proud to champion innovation to enhance patients’ wellbeing. Through PsOlve, we aim to uncover groundbreaking proposals that address the needs of people living with psoriasis. Join the challenge today and collaborate with Almirall to create holistic solutions for psoriasis care. Why participate? 🔹Mentoring opportunity: The four finalists will engage in a mentoring process to develop their initiatives in collaboration with Almirall. 🔹Strategic partnership: The selected proposal will enter a negotiation phase with Almirall for a strategic partnership, including up to €30,000 to pilot and implement the project. 🔹Brand recognition: Gain brand recognition and support for dissemination within the healthcare ecosystem. Submit your proposals by January 31, 2025, and be part of the change in psoriasis care: https://lnkd.in/duAkXu-e #WeAreAlmirall #Innovation #Psoriasis

  • Ver la página de empresa de Almirall, gráfico

    129.903 seguidores

    Today we have announced the launch of our biological treatment for adults and adolescents with moderate to severe atopic dermatitis in Spain. At a press conference in Madrid, our team shared this new milestone, which reflects our firm commitment to medical dermatology and represents a significant advance in our mission to improve the lives of people who are living with atopic dermatitis. #WeAreAlmirall #Innovation #AtopicDermatitis

    • No hay descripción de texto alternativo para esta imagen
    • No hay descripción de texto alternativo para esta imagen
  • Almirall ha compartido esto

    Ver el perfil de Carlos Gallardo, gráfico

    Chairman and CEO at Almirall

    Attending the annual congress of the EADV (European Academy of Dermatology and Venereology) is always a highlight for me. Seeing the latest scientific advancements in understanding the skin and its diseases is very powerful. Discussing the constantly improving treatment options with leading experts in dermatology and clinicians and working together to help patients every day is truly inspirational. With the many interactions at our booth, 37 abstracts, and two dedicated symposia (on Atopic Dermatitis and Psoriasis) the Almirall team is a major contributor to this year´s EADV. Many thanks to the team at the EADV and our outstanding Almirall team for putting together such an impactful #EADV2024 congress in Amsterdam – I am looking forward to more inspiring discussions over the last 1.5 days of the congress here in Amsterdam.   #WeAreAlmirall, #EADV2024, #dermatology, #skinhealth, #medicaldermatology

    • No hay descripción de texto alternativo para esta imagen
  • Ver la página de empresa de Almirall, gráfico

    129.903 seguidores

    Last week, we were present at the Cyber Health & Pharma Summit 2024, which took place in Barcelona, uniting professionals from the cybersecurity and technology fields. Our Senior Director of Information Security, Ramón Serres, participated in a roundtable and shared valuable insights on how Almirall protects its business, customers, and patients in an increasingly complex threat landscape. We are proud to have been part of this insightful event and to contribute to the ongoing dialogue of such a critical risk as cybersecurity in the health and pharma sectors. Thank you to all the participants and organizers for making this summit successful! Together, we will continue to strengthen our defenses and innovate for a safer future. #CyberHealthPharmaSummit  #WeAreAlmirall

    • No hay descripción de texto alternativo para esta imagen
    • No hay descripción de texto alternativo para esta imagen
  • Ver la página de empresa de Almirall, gráfico

    129.903 seguidores

    Connecting with the world's leading experts and engaging in meaningful discussions is crucial to furthering our purpose of improving the lives of people living with skin diseases. That's why we are once again attending as Silver Sponsors the Annual Congress of the European Academy of Dermatology and Venereology in Amsterdam! During these days, we will share our latest scientific advances with the dermatology community, continuing to build a brighter future for people living with skin conditions. Stay tuned for updates and highlights from the #EADVCongress! #MedicalDermatology #WeAreAlmirall

    • No hay descripción de texto alternativo para esta imagen
    • No hay descripción de texto alternativo para esta imagen
    • No hay descripción de texto alternativo para esta imagen
  • Ver la página de empresa de Almirall, gráfico

    129.903 seguidores

    Skin is more than just a protective barrier; it's our sensorial window to the world, and at Almirall, we understand the profound physical and emotional impact skin conditions can have on people's lives. Our commitment to medical dermatology is built on a deep scientific understanding of skin diseases, patients, and dermatologists. With a global presence in 18 countries and more than 50 dermatology products available in over 100 countries, we are dedicated to advancing innovative and effective solutions for skin conditions. ✨Every day at Almirall, we work to help people achieve their hopes and dreams for a healthy life. Watch the video below to see how we do it! #MedicalDermatology #WeAreAlmirall

Páginas similares

Buscar empleos

Financiación

Almirall 1 ronda en total

Última ronda

Equidad tras OPV

215.792.796,00 US$

Ver más información en Crunchbase